Recent literature reports an increase in PKM2 protein expression in the brains of AD patients as they transition from the latency stage to cognitive dysfunction stage, suggesting that elevated PKM2 protein levels may significantly contribute to cognitive dysfunction in AD patients [34]. This evidence concerns the gene PKM and Alzheimer disease.